Nano X Imaging is expected to report a second-quarter loss of $0.16 per share on revenue of $5.39 million, while the stock currently trades at $1.06 against a consensus analyst target of $4.00.
Investors are primarily focused on the company’s liquidity and 'going concern' status after a July update warned that existing cash may not fund operations for another twelve months.
While management recently highlighted new U.S. capital equipment deals for its Nanox.ARC system, preliminary results suggested revenue could fall short of consensus at approximately $4.0 million to $4.1 million.
Market sentiment also remains pressured by a pending securities class action lawsuit deadline that coincides with the earnings release date.